IDM Pharma, Inc. (IDMI)

[bowonwing]

Yea, well, the key here is P.A. As I posted before if P.A. signs off on this merger it is a done deal @$2.64 a share.

Something is worth only what somebody is willing to pay for it. I just do not see IDM's B of D, executive management and P.A. all signing off on this deal unless there were no other credible buyers of the company interested at this time.

I believe there is some information regarding IDM's ability to generate revenue from Mepact that we are not privy too, that either it will cost a lot money to get the revenue flowing, production costs for Mepact will be to high, or perhaps that it will take much more time then we believed. Something is very wrong here and I do not what it is. At least cancer patients will get Mepact.

I made out with about $7K, was looking for triple digits. Yes, we got screwed, big time selling IDM for <$67M! But as I said before, I believe IDM's management put this company behind the eight ball and in the jungle if you sense weakness you pounce and Takeda pounced.

Re: if there is a lawsuit, I have worked in legal for 20 years and the attorneys are the ones who usually win in the end. Still, could be interesting to see how this plays out.